CC BY-NC-ND 4.0 · Laryngorhinootologie 2020; 99(S 02): S141
DOI: 10.1055/s-0040-1710957
Abstracts
Oncology

Head and neck tumor- patient follow -up care – signs and symptoms to look for

S Hadas
1   Klinikum rechts der Isar, München
,
K Feigl
1   Klinikum rechts der Isar, München
,
B Wollenberg
1   Klinikum rechts der Isar, München
,
A Pickhard
1   Klinikum rechts der Isar, München
,
M Buchberger
1   Klinikum rechts der Isar, München
› Author Affiliations
 

Introduction Tumor follow-up-care of patients with head- and neck cancers is challenging for examiners and requires a multidisciplinary team. The aim of this study was to investigate patients’ common complaints, patients’ psychological state and specific blood values.

Methods The patients ´ common complaints (n = 453) were investigated using the EORTC QLQ-H&N35- survey. To calculate the percentage the top two answers (from a total of four) were added together. Additionally, patients ´ filled out the WHO-Five Well-Being Index (range 0-25) questionnaire to screen for the subjective well-being. Patients with a score <13 were subsequently interviewed with the M.I.N.I-questionaire to evaluate a possible depression. All patients were screened for vitamin D and thyroid hormone levels.

Results With the H&N35-evaluation the most common symptoms were screened. These symptoms in the head and neck were xerostomia (48.3 %), sticky saliva (35.3 %), cough (35.0 %), hypoguesia (31.6 %) and dysphagia of solid foods (31.4 %). The average score of the WHO-5-questionaire was 15.5 points. 25,2 % of the patients had a score of <13 points, and 40.9 % of these patients, who were interviewed via M.I.N.I., were classified as depressed (overall collective 8.5 %). Low vitamin D levels were detected in the majority of patients (85.3 %). Hypothyroidism (latent and manifest) was detected in 11.6 % of patients.

Conclusion The symptoms patients presented with were typical for HNSCC tumor patients, especially following radiation therapy. Psychological support proofed to be an extremely important part of tumor follow-up-care. Vitamin D levels and thyroid hormones should be monitored and when necessary therapy should be initiated.

Poster-PDF A-1759.PDF



Publication History

Article published online:
10 June 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

© Georg Thieme Verlag KG
Stuttgart · New York